Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.90 CAD
27.51 M CAD
28.56 M CAD
14.83 M
About CIPHER PHARMACEUTICALS INC
Sector
CEO
Craig Mull
Headquarters
Mississauga
Website
Founded
2000
FIGI
BBG000BSKPS7
Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. Its products include dermatology, hospital acute care, and out-licensed products. The company was founded in 2000 and is headquartered in Mississauga, Canada.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CPH is 14.74 CAD — it has increased by 0.55% in the past 24 hours. Watch CIPHER PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange CIPHER PHARMACEUTICALS INC stocks are traded under the ticker CPH.
CPH stock has risen by 6.73% compared to the previous week, the month change is a 1.94% rise, over the last year CIPHER PHARMACEUTICALS INC has showed a 157.24% increase.
We've gathered analysts' opinions on CIPHER PHARMACEUTICALS INC future price: according to them, CPH price has a max estimate of 18.60 CAD and a min estimate of 14.53 CAD. Watch CPH chart and read a more detailed CIPHER PHARMACEUTICALS INC stock forecast: see what analysts think of CIPHER PHARMACEUTICALS INC and suggest that you do with its stocks.
CPH stock is 2.28% volatile and has beta coefficient of −1.24. Track CIPHER PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is CIPHER PHARMACEUTICALS INC there?
Today CIPHER PHARMACEUTICALS INC has the market capitalization of 377.19 M, it has increased by 2.09% over the last week.
Yes, you can track CIPHER PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
CIPHER PHARMACEUTICALS INC is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
CPH earnings for the last quarter are 0.01 CAD per share, whereas the estimation was 0.19 CAD resulting in a −92.86% surprise. The estimated earnings for the next quarter are 0.27 CAD per share. See more details about CIPHER PHARMACEUTICALS INC earnings.
CIPHER PHARMACEUTICALS INC revenue for the last quarter amounts to 14.03 M CAD, despite the estimated figure of 14.21 M CAD. In the next quarter, revenue is expected to reach 16.90 M CAD.
CPH net income for the last quarter is 386.00 K CAD, while the quarter before that showed 4.10 M CAD of net income which accounts for −90.58% change. Track more CIPHER PHARMACEUTICALS INC financial stats to get the full picture.
No, CPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 9.00 employees. See our rating of the largest employees — is CIPHER PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CIPHER PHARMACEUTICALS INC EBITDA is 14.69 M CAD, and current EBITDA margin is 53.21%. See more stats in CIPHER PHARMACEUTICALS INC financial statements.
Like other stocks, CPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CIPHER PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CIPHER PHARMACEUTICALS INC technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CIPHER PHARMACEUTICALS INC stock shows the buy signal. See more of CIPHER PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.